BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 10690545)

  • 1. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
    Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
    Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
    Freitas S; Moore DH; Michael H; Kelley MR
    Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme.
    Duguid JR; Eble JN; Wilson TM; Kelley MR
    Cancer Res; 1995 Dec; 55(24):6097-102. PubMed ID: 8521399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
    Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
    Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
    Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
    Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer.
    Xu Y; Moore DH; Broshears J; Liu L; Wilson TM; Kelley MR
    Anticancer Res; 1997; 17(5B):3713-19. PubMed ID: 9427767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas.
    Tanner B; Grimme S; Schiffer I; Heimerdinger C; Schmidt M; Dutkowski P; Neubert S; Oesch F; Franzen A; Kölbl H; Fritz G; Kaina B; Hengstler JG
    Gynecol Oncol; 2004 Feb; 92(2):568-77. PubMed ID: 14766249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1.
    Fritz G; Kaina B
    Oncogene; 1999 Jan; 18(4):1033-40. PubMed ID: 10023679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury.
    Lewén A; Sugawara T; Gasche Y; Fujimura M; Chan PH
    Neurobiol Dis; 2001 Jun; 8(3):380-90. PubMed ID: 11447995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas.
    Puglisi F; Barbone F; Tell G; Aprile G; Pertoldi B; Raiti C; Kelley MR; Damante G; Sobrero A; Beltrami CA; Di Loreto C
    Oncol Rep; 2002; 9(1):11-7. PubMed ID: 11748448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA repair activity of human redox/repair protein APE/Ref-1 is inactivated by phosphorylation.
    Yacoub A; Kelley MR; Deutsch WA
    Cancer Res; 1997 Dec; 57(24):5457-9. PubMed ID: 9407949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice.
    Fujimura M; Morita-Fujimura Y; Kawase M; Chan PH
    J Cereb Blood Flow Metab; 1999 May; 19(5):495-501. PubMed ID: 10326716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells.
    Robertson KA; Hill DP; Xu Y; Liu L; Van Epps S; Hockenbery DM; Park JR; Wilson TM; Kelley MR
    Cell Growth Differ; 1997 Apr; 8(4):443-9. PubMed ID: 9101090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells.
    Yang S; Misner BJ; Chiu RJ; Meyskens FL
    Carcinogenesis; 2007 Nov; 28(11):2382-90. PubMed ID: 17566060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
    Wei SJ; Botero A; Hirota K; Bradbury CM; Markovina S; Laszlo A; Spitz DR; Goswami PC; Yodoi J; Gius D
    Cancer Res; 2000 Dec; 60(23):6688-95. PubMed ID: 11118054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of apurinic/apyrimidinic endonuclease (Ape, Ref-1) by oxidative stress requires CREB.
    Grösch S; Kaina B
    Biochem Biophys Res Commun; 1999 Aug; 261(3):859-63. PubMed ID: 10441516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of human apurinic/apyrimidinic endonuclease (APE/Ref-1) expression in rectal cancer treated with preoperative radiochemotherapy.
    Kim JS; Kim JM; Liang ZL; Jang JY; Kim S; Huh GJ; Kim KH; Cho MJ
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):130-7. PubMed ID: 21075552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.
    Seemann S; Hainaut P
    Oncogene; 2005 Jun; 24(24):3853-63. PubMed ID: 15824742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the DNA repair protein, N-methylpurine-DNA glycosylase (MPG) in human gonads.
    Kim NK; An HJ; Kim HJ; Sohn TJ; Roy R; Oh D; Ahn JY; Hwang TS; Cha KY
    Anticancer Res; 2002; 22(2A):793-8. PubMed ID: 12014652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.